A genetic screening study may help design better sleeping sickness drugs and avoid growing drug resistance.

Novel materials that fit inside a vaccine-carrying box could help prevent vaccines spoiling before use.

A new cholera prediction model can warn of outbreaks 11 months in advance and also describe the possible severity.

Critics have questioned the methods of a study claiming that the WHO has greatly underestimated the number of malaria fatalities.

Pakistan's medical laboratory workers need better biosafety awareness says a new study.

A drug undergoing clinical trials for sleeping sickness could also treat leishmaniasis, say researchers who have tested it on mice.

Science institutions from Argentina, Brazil, Paraguay and Uruguay are collaborating on the study of high-impact diseases in the region.

Unprecedented collaboration by drug firms, ambitious targets and more funds form part of a new fight against neglected tropical diseases.

A vaccine for meningococcal B has provided 99 per cent protection against the disease in a clinical trial in Chilean teens.

The Argentinean government and a public-private consortium have allocated US$1.2  million for the improvement of early diagnosis of Chagas disease in newborns.

A modelling study of a promising malaria vaccine finds low transmission areas would benefit the most from mass vaccination.

China's largest biotechnology company and a non-profit product developer are teaming up to develop new tuberculosis vaccines.

The origin of two genetic sub-types of the malaria parasite P. falciparum in South America has been traced back slaves arriving from Africa, a study says.

The key malaria drug, artemisinin, can now be produced in greater quantities ― from a waste material of the current production process.

Indian health officials are describing hard to treat cases of TB as 'extra XDR-TB' amid warnings that the disease is not being managed properly.

A Nicaraguan study is helping scientists understand why a second dengue fever infection can be more severe than the first one.

A retrospective study of tweets on the 2010 cholera epidemic in Haiti found them broadly as good as official data at predicting its progress.

An award-winning, rapid test for hepatitis C that uses gold nanoparticles could be especially useful in the Middle East and North Africa.

A vaccine candidate that exploits how the malaria parasite enters human red blood cells is set to enter safety trials.

Silk 'chips' capable of diagnosing a range of diseases in a matter of minutes could be ready for market by early 2013.